Merck

4. Merck

Total Ad Spend: $285.5 million
Television: $133.7 million
Magazine: $87.8 million
Other: $64 million

After resolving the manufacturing and supply problems that constricted supplies of Zostavax for several years, Merck ($MRK) decided on a disease-awareness campaign to herald its revival in the market. The campaign must have worked, because Zostavax was one of the best-selling vaccines last year.


In the spotlight

Shingles awareness, $46.7 million
Nasonex, $46.3 million
Zostavax, $46 million


 

Merck
Read more on

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.